Manu Ammatuna

Dr. Manu Ammatuna is a researcher specializing in hematology and oncology, with a focus on leukemia and chemotherapy strategies. As an Editor of Critical Reviews in Oncology/Hematology since 2019, he contributes to peer-review and editorial work in academic publishing. His research explores acute myeloid leukemia (AML), chemotherapy efficacy, genomics-based prognostic indices, and global healthcare challenges in treating hematologic malignancies.

Research interests include: Acute Myeloid Leukemia, Chemotherapy Resistance, FLT3 Mutations, Prognostic Biomarkers, Global Health Access, and Autoimmune Skin Diseases. Recent work analyzes treatment protocols for polycythemia vera, evaluates midostaurin in AML patients, and investigates gene-based survival prediction models.

His articles highlight trends in precision medicine for blood cancers and disparities in leukemia care across different income regions. Collaborations span international teams addressing both clinical and translational aspects of hematologic disorders.